Int J Cardiol:房颤患者心衰类型与血栓栓塞风险!

2018-04-23 xing,T MedSci原创

由此可见,该研究表明,LVEF减少与较高的血栓栓塞风险有关,但与较高的出血风险无关。HFHpEF是一个独特且令人困惑的类别,其特征是CHA2DS2-VASC评分最高,但血栓栓塞事件的残留风险最低,这值得进一步研究。

近日,心血管领域权威杂志International Journal of Cardiology上发表了一篇研究文章,研究人员旨在根据心力衰竭类型以评估心衰合并房颤患者的血栓栓塞和出血风险。

研究人员分析了6170例来自于欧洲房颤患者登记中心血栓栓塞事件预防研究的房颤患者,并将患者分为:左室射血分数降低的心衰患者(HFrEF;LVEF<40%);EF中等的心衰患者(HFmrEF;LVEF:40~49%);EF正常较低的心衰患者(HFpEF;LVEF:50~60%),EF正常较高的心衰患者(HFHpEF,LVEF>60%)和无心衰患者。该研究的结局为缺血性卒中、主要不良心血管和脑血管事件(MACE)和1年内发生的大出血。

研究人员发现卒中的年发病率与LVEF呈线性负相关,LVEF每下降1%,卒中发病率增加0.054%(95%CI为0.013%~0.096%;P=0.031)。HFHpEF患者的CHA2DS2-VASC评分最高,但卒中发生率显著低于其他心衰组(0.65%,HFLpEF为1.30%;HFmrEF 1.71%;HFrFF为1.75%;趋势P=0.014)。与其他心衰组相比,HFHpEF组(2%)MACCE的发生率也较低(范围为3.8~4.4%;P=0.001)。年龄、HF类型和NYHA级别是血栓栓塞事件的独立预测因素。相反,大出血事件组间差异无统计学意义(P=0.168)。

由此可见,该研究表明,LVEF减少与较高的血栓栓塞风险有关,但与较高的出血风险无关。HFHpEF是一个独特且令人困惑的类别,其特征是CHA2DS2-VASC评分最高,但血栓栓塞事件的残留风险最低,这值得进一步研究。

原始出处:


Jolanta M. Siller-Matula,et al. Heart failure subtypes and thromboembolic risk in patients with atrial fibrillation: The PREFER in AF - HF substudy.International Journal of Cardiology.2018. https://doi.org/10.1016/j.ijcard.2018.04.093

本文系梅斯医学(MedSci)原创编译整理,转载需授权!


版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1781905, encodeId=1db91e819057f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 18 20:33:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614449, encodeId=267f161444958, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Apr 25 11:33:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308762, encodeId=059d308e6225, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 24 07:45:03 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308621, encodeId=6342308621bd, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Mon Apr 23 21:01:34 CST 2018, time=2018-04-23, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1781905, encodeId=1db91e819057f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 18 20:33:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614449, encodeId=267f161444958, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Apr 25 11:33:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308762, encodeId=059d308e6225, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 24 07:45:03 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308621, encodeId=6342308621bd, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Mon Apr 23 21:01:34 CST 2018, time=2018-04-23, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1781905, encodeId=1db91e819057f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 18 20:33:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614449, encodeId=267f161444958, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Apr 25 11:33:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308762, encodeId=059d308e6225, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 24 07:45:03 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308621, encodeId=6342308621bd, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Mon Apr 23 21:01:34 CST 2018, time=2018-04-23, status=1, ipAttribution=)]
    2018-04-24 张新亮1853311252142e2fm

    好文献.学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1781905, encodeId=1db91e819057f, content=<a href='/topic/show?id=5db8409ed8' target=_blank style='color:#2F92EE;'>#Cardiol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4097, encryptionId=5db8409ed8, topicName=Cardiol)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8e886, createdName=仁者大医, createdTime=Mon Jun 18 20:33:00 CST 2018, time=2018-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1614449, encodeId=267f161444958, content=<a href='/topic/show?id=64f95426122' target=_blank style='color:#2F92EE;'>#房颤患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=54261, encryptionId=64f95426122, topicName=房颤患者)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=937e19519012, createdName=hittouch, createdTime=Wed Apr 25 11:33:00 CST 2018, time=2018-04-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308762, encodeId=059d308e6225, content=好文献.学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=b5a62240667, createdName=张新亮1853311252142e2fm, createdTime=Tue Apr 24 07:45:03 CST 2018, time=2018-04-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=308621, encodeId=6342308621bd, content=了解一下.谢谢分享!, beContent=null, objectType=article, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/12/23/2f51002e1349ccda5be11c1eea1e1e60.jpg, createdBy=a22097948, createdName=天地飞扬, createdTime=Mon Apr 23 21:01:34 CST 2018, time=2018-04-23, status=1, ipAttribution=)]
    2018-04-23 天地飞扬

    了解一下.谢谢分享!

    0

相关资讯

JAHA:焦虑可增加房颤患者的卒中发生风险!

焦虑和抑郁会加重许多心血管疾病的预后结局,然而其是否会影响房颤患者的预后尚属未知。本研究的目的旨在评估房颤患者中焦虑和/或抑郁是否与卒中和出血事件的发生相关。本研究纳入了2004年至2007年WAVE数据库中接受华法林治疗的房颤患者,通过电子病历记录对患者进行焦虑和抑郁的诊断。最终共纳入了25570名房颤患者,其中490名患者出现了卒中或脑出血(1.52次/100人年),多变量分析后发现,焦虑会增

JAHA:BMI与房颤的发生风险呈正相关

房颤的发病率逐年增加,体重指数(BMI)是房颤的危险因素,然而,性别在BMI对房颤影响中的作用尚不清楚。本研究纳入了Troms?第四次临床研究中的24799名研究对象(平均年龄为45.5±14.2岁,女性占52.9%),经过平均15.7±5.5年时间的随访,有811名(6.2%)女性和918名(7.9%)男性发展为房颤,在男性中,低的BMI可以降低房颤的发生风险,而高BMI会增加房颤的风险(HR:

SCI REP:房颤、心房增大与左心室几何重构的关系!

总之,房颤的患病率随着LV几何重构的模式而增加,并且与左心房大小和LVEF相关。

Circulationg:房颤诊疗存在重大疏漏!不能仅以房颤发作或终止作为评价标准,要重视房颤负荷

昨日,Circulation杂志在线发表科学声明,指出目前临床多根据房颤类型进行相应的研究,包括阵发性与非阵发性、持续性或永久性房颤,推荐使用危险评分(CHA2DS2-VASc)进行抗凝治疗。但这存在重大疏漏:如果仅以有房颤或无房颤来描述太片面!今后要考虑房颤负荷问题。

JAHA:外周动脉疾病与房颤发生之间的相关性!

由此可见,较低ABI诊断的外周动脉疾病,包括边界性ABI,是房颤一个较弱的危险因素。ABI>1.4与房颤风险增加无关。外周动脉疾病与房颤之间的关系主要是由传统的动脉粥样硬化危险因素来解释。

Circulation:房颤女性口服抗凝决策:CHA2DS2-VA or CHA2DS2-VASc评分?

2018年2月,发表在《Circulation》的一项由丹麦和英国科学家进行的研究考察,女性性别是房颤患者卒中的风险调节因素而非风险因素:我们应该使用CHA2DS2-VA评分而非CHA2DS2-VASc评分?